Aguillard Mark Bryan 4
4 · DermTech, Inc. · Filed Sep 22, 2023
Insider Transaction Report
Form 4
DermTech, Inc.DMTK
Aguillard Mark Bryan
Chief Commercial Officer
Transactions
- Award
Common Stock
2023-09-20+90,000→ 90,000 total - Award
Stock Option (right to buy)
2023-09-20+90,000→ 90,000 totalExercise: $1.69Exp: 2033-09-20→ Common Stock (90,000 underlying)
Footnotes (2)
- [F1]The securities awarded are in the form of restricted stock units issued pursuant to the issuer's 2022 Inducement Plan, as amended. Each restricted stock unit represents a contingent right to receive one share of issuer common stock. Subject to the reporting person's continued service, (i) twelve forty-eighths (12/48) of the restricted stock units shall vest on September 20, 2024 and (ii) the remaining the remaining thirty-six forty-eighths (36/48) shall vest in twelve (12) equal installments of three forty-eighths (3/48) on the twentieth day of each third month following September 20, 2024 until the final vesting date on September 20, 2027.
- [F2]Subject to the reporting person's continued service, (i) twelve forty-eighths (12/48) of the shares of issuer common stock exercisable pursuant to this option shall vest on September 20, 2024 and (ii) the remaining thirty-six forty-eighths (36/48) shall vest in a series of thirty-six (36) equal monthly installments of one forty-eighth (1/48) over the thirty-six (36) months thereafter until the final vesting date on September 20, 2027.